177 related articles for article (PubMed ID: 25736604)
21. Structure of serum amyloid A suggests a mechanism for selective lipoprotein binding and functions: SAA as a hub in macromolecular interaction networks.
Frame NM; Gursky O
FEBS Lett; 2016 Mar; 590(6):866-79. PubMed ID: 26918388
[TBL] [Abstract][Full Text] [Related]
22. Influence of the carboxy terminus of serum amyloid A on protein oligomerization, misfolding, and fibril formation.
Patke S; Maheshwari R; Litt J; Srinivasan S; Aguilera JJ; Colón W; Kane RS
Biochemistry; 2012 Apr; 51(14):3092-9. PubMed ID: 22448726
[TBL] [Abstract][Full Text] [Related]
23. Induction of murine AA amyloidosis by various homogeneous amyloid fibrils and amyloid-like synthetic peptides.
Liu Y; Cui D; Hoshii Y; Kawano H; Une Y; Gondo T; Ishihara T
Scand J Immunol; 2007 Nov; 66(5):495-500. PubMed ID: 17953525
[TBL] [Abstract][Full Text] [Related]
24. Amyloidogenesis recapitulated in cell culture: a peptide inhibitor provides direct evidence for the role of heparan sulfate and suggests a new treatment strategy.
Elimova E; Kisilevsky R; Szarek WA; Ancsin JB
FASEB J; 2004 Nov; 18(14):1749-51. PubMed ID: 15345688
[TBL] [Abstract][Full Text] [Related]
25. Animal models for reactive amyloidosis.
Gruys E; Snel FW
Baillieres Clin Rheumatol; 1994 Aug; 8(3):599-611. PubMed ID: 7954864
[TBL] [Abstract][Full Text] [Related]
26. Structural requirements of glycosaminoglycans for facilitating amyloid fibril formation of human serum amyloid A.
Takase H; Tanaka M; Yamamoto A; Watanabe S; Takahashi S; Nadanaka S; Kitagawa H; Yamada T; Mukai T
Amyloid; 2016 Jun; 23(2):67-75. PubMed ID: 27097047
[TBL] [Abstract][Full Text] [Related]
27. Why working with porcine circulating serum amyloid A is a pig of a job.
Soler L; Molenaar A; Merola N; Eckersall PD; Gutiérrez A; Cerón JJ; Mulero V; Niewold TA
J Theor Biol; 2013 Jan; 317():119-25. PubMed ID: 23073471
[TBL] [Abstract][Full Text] [Related]
28. Cystatin C binds serum amyloid A, downregulating its cytokine-generating properties.
Bokarewa M; Abrahamson M; Levshin N; Egesten A; Grubb A; Dahlberg L; Tarkowski A
J Rheumatol; 2007 Jun; 34(6):1293-301. PubMed ID: 17552057
[TBL] [Abstract][Full Text] [Related]
29. Heparan sulfate dissociates serum amyloid A (SAA) from acute-phase high-density lipoprotein, promoting SAA aggregation.
Noborn F; Ancsin JB; Ubhayasekera W; Kisilevsky R; Li JP
J Biol Chem; 2012 Jul; 287(30):25669-77. PubMed ID: 22654109
[TBL] [Abstract][Full Text] [Related]
30. Serum amyloid A forms stable oligomers that disrupt vesicles at lysosomal pH and contribute to the pathogenesis of reactive amyloidosis.
Jayaraman S; Gantz DL; Haupt C; Gursky O
Proc Natl Acad Sci U S A; 2017 Aug; 114(32):E6507-E6515. PubMed ID: 28743750
[TBL] [Abstract][Full Text] [Related]
31. Exploring the 'aggregation-prone' core of human Cystatin C: A structural study.
Tsiolaki PL; Louros NN; Hamodrakas SJ; Iconomidou VA
J Struct Biol; 2015 Sep; 191(3):272-80. PubMed ID: 26235923
[TBL] [Abstract][Full Text] [Related]
32. Relation between serum amyloid A truncated peptides and their suprastructure chirality.
Rubin N; Perugia E; Wolf SG; Klein E; Fridkin M; Addadi L
J Am Chem Soc; 2010 Mar; 132(12):4242-8. PubMed ID: 20218685
[TBL] [Abstract][Full Text] [Related]
33. Channel formation by serum amyloid A: a potential mechanism for amyloid pathogenesis and host defense.
Hirakura Y; Carreras I; Sipe JD; Kagan BL
Amyloid; 2002 Mar; 9(1):13-23. PubMed ID: 12000193
[TBL] [Abstract][Full Text] [Related]
34. Structural Basis for Vital Function and Malfunction of Serum Amyloid A: an Acute-Phase Protein that Wears Hydrophobicity on Its Sleeve.
Gursky O
Curr Atheroscler Rep; 2020 Sep; 22(11):69. PubMed ID: 32968930
[TBL] [Abstract][Full Text] [Related]
35. Effect of zinc, copper, and calcium on the structure and stability of serum amyloid A.
Wang L; Colón W
Biochemistry; 2007 May; 46(18):5562-9. PubMed ID: 17425332
[TBL] [Abstract][Full Text] [Related]
36. AA-amyloidosis. Tissue component-specific association of various protein AA subspecies and evidence of a fourth SAA gene product.
Westermark GT; Sletten K; Grubb A; Westermark P
Am J Pathol; 1990 Aug; 137(2):377-83. PubMed ID: 2386201
[TBL] [Abstract][Full Text] [Related]
37. Generation and use of site-specific antibodies to serum amyloid A for probing amyloid A development.
Miura K; Ju ST; Cohen AS; Shirahama T
J Immunol; 1990 Jan; 144(2):610-3. PubMed ID: 2295803
[TBL] [Abstract][Full Text] [Related]
38. NMR and CD spectroscopy show that imino acid restriction of the unfolded state leads to efficient folding.
Xu Y; Hyde T; Wang X; Bhate M; Brodsky B; Baum J
Biochemistry; 2003 Jul; 42(29):8696-703. PubMed ID: 12873129
[TBL] [Abstract][Full Text] [Related]
39. Increased circulating serum amyloid A protein derivatives in rheumatoid arthritis patients with secondary amyloidosis.
Migita K; Eguchi K; Tsukada T; Kawabe Y; Takashima H; Mine M; Aoyagi T; Ichinose Y; Nagataki S
Lab Invest; 1996 Sep; 75(3):371-5. PubMed ID: 8804360
[TBL] [Abstract][Full Text] [Related]
40. Serum amyloid A binds specific extracellular matrix glycoproteins and induces the adhesion of resting CD4+ T cells.
Preciado-Patt L; Hershkoviz R; Fridkin M; Lider O
J Immunol; 1996 Feb; 156(3):1189-95. PubMed ID: 8557997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
